Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and …

X Bao, R Shi, T Zhao, Y Wang, N Anastasov… - Cancer Immunology …, 2021 - Springer
Triple-negative breast cancer (TNBC) is characterized by a more aggressive clinical course
with extensive inter-and intra-tumour heterogeneity. Combination of single-cell and bulk …

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

M Karaayvaz, S Cristea, SM Gillespie, AP Patel… - Nature …, 2018 - nature.com
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by extensive
intratumoral heterogeneity. To investigate the underlying biology, we conducted single-cell …

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple …

S Guo, X Liu, J Zhang, Z Huang, P Ye, J Shi… - Computers in biology …, 2023 - Elsevier
Background Triple negative breast cancer (TNBC) is an aggressive and fatal malignancy.
The current success of tumor immunotherapy has focused attention on intermediate T-cell …

[PDF][PDF] Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach

Y Bareche, L Buisseret, T Gruosso… - JNCI: Journal of the …, 2020 - academic.oup.com
Background Recent efforts of gene expression profiling analyses recognized at least four
different triple-negative breast cancer (TNBC) molecular subtypes. However, little is known …

Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer

Y Xiao, D Ma, S Zhao, C Suo, J Shi, MZ Xue… - Clinical cancer …, 2019 - AACR
Purpose: The tumor microenvironment has a profound impact on prognosis and
immunotherapy. However, the landscape of the triple-negative breast cancer (TNBC) …

Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks

S Zhou, Y Huang, H Liu, X Zhou, M Yuan, F Hou… - … Therapy-Nucleic Acids, 2021 - cell.com
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with high intratumoral
heterogeneity. Recent studies revealed that TNBC patients might comprise cells with distinct …

M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular …

X Qu, X Zhao, K Lin, N Wang, X Li, S Li… - Frontiers in …, 2022 - frontiersin.org
Background M2-like tumor-associated macrophages (M2-like TAMs) have important roles in
the progression and therapeutics of cancers. We aimed to detect novel M2-like TAM-related …

Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer

SZ Wu, DL Roden, C Wang, H Holliday, K Harvey… - The EMBO …, 2020 - embopress.org
The tumour stroma regulates nearly all stages of carcinogenesis. Stromal heterogeneity in
human triple‐negative breast cancers (TNBCs) remains poorly understood, limiting the …

High densities of tumor-associated plasma cells predict improved prognosis in triple negative breast cancer

J Yeong, JCT Lim, B Lee, H Li, N Chia… - Frontiers in …, 2018 - frontiersin.org
Breast cancer is the most common malignancy affecting women, but the heterogeneity of the
condition is a significant obstacle to effective treatment. Triple negative breast cancers …

Association between genomic metrics and immune infiltration in triple-negative breast cancer

T Karn, T Jiang, C Hatzis, N Sänger, A El-Balat… - JAMA …, 2017 - jamanetwork.com
Importance Why some triple-negative breast cancers (TNBCs) have high and others have
low immune cell infiltration is unknown. Understanding how immune surveillance shapes …